TAKASAGO INTERNATIONAL CORPORATION Country: JapanTAKASAGO INTERNATIONAL CORPORATION http://www.takasago.com/finechemicals/index.htm
Click the play button below for an interview with Christina Zak at Informex Company Profile
The global leader in Catalytic Asymmetric Synthesis. Over 2,000 mt of annual chiral output, Over 260 Catalysts library & Over 20 years industrial production experience. Takasago offers best approaches to chiral compounds utilizing our 3rd generation ligand of SEGPHOS family. SEGPHOS works better than BINAP at least 5 to 10 times and all BINAP chemistry can be replaced to SEGPHOS. Takasago is continuing developments of 4th and 5th generation ligands. cGMP & ISO certified facilities for contract manufacturing. Global Asymmetric Hydrogenation facilities in Japan and Europe. Grignard with low temp, Wide range of reaction capabilities.
Product List: 76 Page:
Ligands (R)-(+)-BINAP (R)-(+)-DM-SEGPHOS (R)-(+)-H8-BINAP (R)-(+)-MOP (R)-(+)-SEGPHOS (R)-(+)-TOLBINAP (R)-(+)-XYLBINAP (R)-(-)-DTBM-SEGPHOS (R,R)-FSDPEN (R,R)-TSDPEN (S)-(+)-DTBM-SEPGHOS (S)-(-)-BINAP (S)-(-)-DM-SEGPHOS (S)-(-)-H8-BINAP (S)-(-)-MOP (S)-(-)-SEGPHOS (S)-(-)-TOLBINAP (S)-(-)-XYLBINAP (S,S)-FSDPEN (S,S)-TSDPEN CBRIDP CY-CBRIDP CY-VBRIDP VBRIDP Catalysts NH2ME2][{RUCL((R)-BINAP)}2(MU-CL)3] NH2ME2][{RUCL((R)-DM-SEGPHOS)}2(MU-CL)3] NH2ME2][{RUCL((R)-H8-BINAP)}2(MU-CL)3] NH2ME2][{RUCL((R)-SEGPHOS)}2(MU-CL)3] NH2ME2][{RUCL((R)-TOLBINAP)}2(MU-CL)3] NH2ME2][{RUCL((R)-XYLBINAP)}2(MU-CL)3] NH2ME2][{RUCL((S)-BINAP)}2(MU-CL)3] NH2ME2][{RUCL((S)-DM-SEGPHOS)}2(MU-CL)3] NH2ME2][{RUCL((S)-H8-BINAP)}2(MU-CL)3] NH2ME2][{RUCL((S)-SEGPHOS)}2(MU-CL)3] NH2ME2][{RUCL((S)-TOLBINAP)}2(MU-CL)3] NH2ME2][{RUCL((S)-XYLBINAP)}2(MU-CL)3] RU(OAC)2[(R)-BINAP] RU(OAC)2[(R)-DM-SEGPHOS] RU(OAC)2[(R)-H8-BINAP] RU(OAC)2[(R)-SEGPHOS] RU(OAC)2[(R)-TOLBINAP] RU(OAC)2[(R)-XYLBINAP] RU(OAC)2[(S)-BINAP] RU(OAC)2[(S)-DM-SEGPHOS] RU(OAC)2[(S)-H8-BINAP] RU(OAC)2[(S)-SEGPHOS] RU(OAC)2[(S)-TOLBINAP] RU(OAC)2[(S)-XYLBINAP] RUCL(P-CYMENE){(R)-BINAP}]CL RUCL(P-CYMENE){(R)-DM-SEGPHOS}]CL RUCL(P-CYMENE){(R)-DTBM-SEGPHOS}]CL RUCL(P-CYMENE){(R)-H8-BINAP}]CL RUCL(P-CYMENE){(R)-SEGPHOS}]CL RUCL(P-CYMENE){(R)-TOLBINAP}]CL RUCL(P-CYMENE){(R)-XYLBINAP}]CL RUCL(P-CYMENE){(S)-BINAP}]CL RUCL(P-CYMENE){(S)-DM-SEGPHOS}]CL RUCL(P-CYMENE){(S)-DTBM-SEGPHOS}]CL RUCL(P-CYMENE){(S)-H8-BINAP}]CL RUCL(P-CYMENE){(S)-SEGPHOS}]CL RUCL(P-CYMENE){(S)-TOLBINAP}]CL RUCL(P-CYMENE){(S)-XYLBINAP}]CL RUCL[(R,R)-FSDPEN](P-CYMENE) RUCL[(R,R)-TSDPEN](MESITYLENE) RUCL[(R,R)-TSDPEN](P-CYMENE) RUCL[(S,S)-FSDPEN](P-CYMENE) RUCL[(S,S)-TSDPEN](MESITYLENE) RUCL[(S,S)-TSDPEN](P-CYMENE) RUCL2[(R)-DM-SEGPHOS][(R)-DAIPEN] RUCL2[(R)-DM-SEGPHOS][(R,R)-DPEN] RUCL2[(R)-XYLBINAP][(R)-DAIPEN] RUCL2[(R)-XYLBINAP][(R,R)-DPEN] RUCL2[(S)-DM-SEGPHOS][(S)-DAIPEN] RUCL2[(S)-DM-SEGPHOS][(S,S)-DPEN] RUCL2[(S)-XYLBINAP][(S)-DAIPEN] RUCL2[(S)-XYLBINAP][(S,S)-DPEN]
